Journal of Cancer and Allied Specialties

The Journal of Cancer and Allied Specialties is an open-access journal dedicated to disseminating high-quality scholarly work in the field of oncology. The journal welcomes submissions of original research articles, comprehensive reviews, and insightful clinical case reports that contribute to the evolving understanding and treatment of cancer.

The Journal of Cancer and Allied Specialties serves as a platform for researchers, clinicians, and healthcare professionals to share findings across a broad spectrum of oncological disciplines, encompassing both experimental and clinical investigations. Key areas of focus include, but are not limited to:

• Adjunct Supportive Care and Palliative Care: Strategies addressing the holistic needs of cancer patients, providing symptom management and supportive care to enhance their quality of life during treatment.
• Cancer Biology: Investigations into the biological mechanisms underlying cancer and tumor development.
• Chemotherapy: Research into the mechanisms of action, efficacy, and toxicity of chemotherapeutic agents.
• Cancer Diagnostics: Advancements in diagnostic modalities, including imaging techniques, molecular diagnostics, and liquid biopsies, for early detection and personalized oncological treatment strategies.
• Cancer Epidemiology: Studies examining the incidence, distribution, and risk factors associated with various cancers.
• Cancer Epigenomics and Genomics: Research into the role of epigenetic modifications and genetic alterations in cancer development and therapeutic responses.
• Cancer Immunology and Immunotherapy: Studies focused on the immune system's role in cancer and the development of immunotherapeutic approaches.
• Radiotherapy: Research on advanced radiotherapeutic techniques and their effectiveness in cancer treatment.
• Surgical Oncology: Advancements in surgical techniques and approaches for cancer resection and management.
• Transplant Oncology: Exploration of transplantation's role in treating hematological malignancies and other cancers.